2021 Oncology Biosimilar Guide to Patient Support Services

In 2020, Mylan and Pfizer’s Upjohn combined to form VIATRIS™. The new company brings together Mylan’s diverse portfolio across many geographies and key therapeutic areas and its robust pipeline, high-quality manufacturing, and supply chain excellence with Upjohn’s trusted brands and proven commercialization capabilities, including leadership positions in China and other emerging markets. Read More ›

Amgen Assist 360 provides several support services for insured, uninsured, and underinsured patients who encounter financial hardships and cannot afford the Amgen biosimilar medications they are prescribed, including Amgen FIRST STEP and the Amgen Safety Net Foundation. Read More ›

Coherus BioSciences’ Coherus COMPLETE offers comprehensive reimbursement and patient support services for patients receiving treatment with Udenyca (pegfilgrastim-cbqv) who are unable to afford this medication, along with provider service programs to help access Udenyca and secure patient reimbursements. Read More ›

Merck Helps offers a full suite of support services, including the Merck Access Program and the Merck Patient Assistance Program, to facilitate access to Merck’s drugs for eligible patients who are unable to afford their Merck medications, regardless of their insurance status. Read More ›

Pfizer Oncology Together is a personalized support program offering patients access to Pfizer Oncology medications. This program helps with the reimbursement process and helps to identify financial assistance for patients who are prescribed Pfizer Oncology medications. Pfizer Oncology Together will connect patients with financial assistance resources, regardless of their insurance coverage. Read More ›

Sandoz, through Sandoz One Source, offers a comprehensive patient support program designed to help simplify patient access to Zarxio (filgrastim-sndz), a biosimilar to Neupogen, and to Ziextenzo (pegfilgrastim-bmez), a biosimilar to Neulasta. Read More ›

Teva Oncology offers access to oncology medications from Teva through Teva Comprehensive Oncology Reimbursement Expertise (CORE) and the Teva Cares Foundation Patient Assistance Program. Read More ›

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to receive the free OPM print publications or weekly e‑Newsletter.

I'd like to receive: